Clinical Trials
12 trialsNCT06019130 2024-05-16
NPC-Nivo
German Society for Pediatric Oncology and Hematology GPOH gGmbH
Phase 2 Recruiting
NCT05385926 2024-02-05
Combining RT With Immunotherapy and Chemotherapy in Metastatic Nasopharyngeal Carcinoma
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2 Unknown
NCT03890185 2019-03-26
Docetaxal & Cisplatin vs LDFRT + Docetaxal & Cisplatin in Locally Advanced NPC
King Faisal Specialist Hospital & Research Center
Phase 2 Unknown
NCT03175939 2017-06-05
Elimination of Adjuvant Chemotherapy for Selected Stage II and III Nasopharyngeal Carcinoma
Sun Yat-sen University
Phase 2 Completed
NCT00002999 2015-05-27
S9715, Chemotherapy and Radiation Therapy in Treating Patients With Advanced Cancer of the Nasopharynx
SWOG Cancer Research Network
Phase 2 Withdrawn
NCT00003251 2013-12-04
Amifostine Plus Chemotherapy and Radiation Therapy in Treating Patients With Advanced, Unresectable Head and Neck Cancer
National Cancer Institute (NCI)
Phase 1/2 Unknown
NCT00008398 2013-11-19
Sargramostim in Decreasing Mucositis in Patients Receiving Radiation Therapy for Head and Neck Cancer
Radiation Therapy Oncology Group
Phase 3 Completed
NCT00004097 2013-09-20
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced and/or Recurrent Head and Neck Cancer
National Cancer Institute (NCI)
Phase 1 Unknown
NCT00002951 2013-09-05
Chemotherapy Plus Radiation Therapy in Treating Patients With Head and Neck Cancer
University of Chicago
Phase 2 Completed
NCT00637637 2013-08-12
External-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain Metastases
National Cancer Institute (NCI)
Phase 2 Unknown
NCT00025298 2012-09-24
Chemotherapy Plus Radiation Therapy With or Without Amifostine in Treating Patients With Locally Advanced Cancer of the Nasopharynx
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2 Terminated
NCT00004164 2009-02-09
Combination Chemotherapy in Treating Patients With Stage IIB, Stage III, or Stage IV Cancer of the Nasopharynx
National Cancer Institute (NCI)
Phase 2 Unknown